Prevacus, Inc. logo

Prevacus, Inc.

Prevacus is a development stage company focusing on a new treatment for concussions. Prevacus is commercializing and developing a proprietary formalization, Prevasol, which can successfully treat and prevent the effects of a mild traumatic brain injury (mTBI-concussion).

Prevacus Inc. is a spun out from Florida State University. Dr. VanLandingham, founder of Prevacus, serves as a professor of neuroscience at Florida State University Department of Biomedical Sciences.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttp://prevacus.com
Founded2012
Disease Focus
Development Stage
STOCK CODENon Listed
Address
1400 Village Square Blvd. Suite 3 #414, FL 32312
Tallahassee
United States
Email
Contact Number
+1 850-765-5054

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/prevacus-incorporated” connections=”true” suffix=””]